OBIO

6.5806.00%
DP

David P. Hochman

Founder, Chairman of the Board of Directors & CEO

Mr. David P. Hochman is Founder & Director at Orchestra BioMed Holdings Inc. (formerly known as Health Sciences Acquisitions Corporation 2) since May 2018 and serves as its Chief Executive Offer and Chairman of the Board of Directors. He has been Chairman of the Board of Opco since 2011. He was a co-Founder of BackBeat Medical, Inc. a wholly owned subsidiary of Health Sciences Acquisitions Corporation 2 (formerly known as Orchestra BioMed, Inc.) and served as its President and a Member of its Board since inception in 2010 until 2018. Mr. Hochman was the Managing Partner of Orchestra Medical Ventures, LLC since June 2006 until 2019. Since May 2018, he has been Chairman and Chief Executive Officer of Health Sciences Acquisitions Corporation 2 (formerly known as Orchestra BioMed, Inc.) He serves as the Managing Partner at Orchestra Partners, LLC. He serves as the President of Accelerated Technologies, Inc (ATI). He has venture capital and investment banking experience. FounderPrior to joining Orchestra, he served as the Chief Executive Officer of Spencer Trask Edison Partners, LLC from March 2004 to June 2006, focused on leveraging human capital to benefit emerging growth healthcare and technology companies. From June 2000 to June 2006, he served as the Managing Director of Spencer Trask Ventures, Inc. (now known as Augment Securities, Inc.), where he served as Managing Director of Venture Resources from June 2000 to March 2004 and was responsible for directing the firm's investment banking and strategic advisory services. He was responsible for directing the firm's venture banking group and led financing transactions for over 20 early-stage companies. He served as Vice President at Spencer Trask Private Equity Fund I, LP and Augment Securities, Inc. He was Co-Founded PROLOR Biotech, Inc. in 2005. He co-founded Prescient Medical, Inc. in 2004. He served as a Board Advisor to Idera Pharmaceuticals, Inc. Mr. Hochman served as a Board Advisor of Health Dialog Services Corporation from 1999 to 2006. Mr. Hochman served as a Vice President of Spencer Trask Ventures, Inc. Prior to that, he served as Vice President of Investment Banking at Spencer Trask Access Corp. He served as Vice Chairman of Naked Brand Group Inc. from May 2015 to October 20, 2017 and served as its Director from June 10, 2014 to October 20, 2017. He had been Director of Corbus Pharmaceuticals Holdings, Inc. since December 2013 until September 11, 2020. He serves as a Director Ventures, Inc. from December 1998 to June 2000. He served as Chairman at Vital Access Corp. and MOTUS GI Medical Technologies Ltd. He serves as the Chairman and Director of Modigene, Inc. and Prescient Medical, Inc. He served as a Director of MOTUS GI Medical Technologies Ltd since 2011 until September 2023 and serves as a Director of Maternity Neighborhood. He was a co-Founder of FreeHold Surgical, Inc. and served as a Member of its Board from 2011 until 2018. He serves as a Member of the Board of AIDS Action Foundation and of Citizens for NYC and the Mollie Parnis Livingston Foundation, for which he also serves as President. He serves as an Observer to the Board of Directors of Hybridon, Inc. He serves as Director at Naked Inc. He served as co-Founder and Director of PROLOR Biotech, Inc. from 2005 to 2007. He had been the Chairman of Motus GI Holdings, Inc. since 2016 until April 13, 2023 and served as its Independent Director until September 06, 2023. He was Co-Founder of Caliber Therapeutics, Inc. and served its Chairman of the Board from 2009 to 2018. He served as a Director of Orchestra Therapeutics, Inc. (formerly, The Immune Response Corp.) from April 2004 to August 24, 2007. Mr. Hochman holds B.A. degree with honors from the University of Michigan. He had been a Director at Adgero Biopharmaceuticals Holdings, Inc. since November 2015 and Adgero Biopharmaceuticals, Inc. since October 10, 2017.

Positions